Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Extracellular traps released by antimicrobial TH17 cells contribute to host defense
George W. Agak, … , Matteo Pellegrini, Robert L. Modlin
George W. Agak, … , Matteo Pellegrini, Robert L. Modlin
Published November 19, 2020
Citation Information: J Clin Invest. 2021;131(2):e141594. https://doi.org/10.1172/JCI141594.
View: Text | PDF
Research Article Immunology

Extracellular traps released by antimicrobial TH17 cells contribute to host defense

  • Text
  • PDF
Abstract

TH17 cell subpopulations have been defined that contribute to inflammation and homeostasis, yet the characteristics of TH17 cells that contribute to host defense against infection are not clear. To elucidate the antimicrobial machinery of the TH17 subset, we studied the response to Cutibacterium acnes, a skin commensal that is resistant to IL-26, the only known TH17-secreted protein with direct antimicrobial activity. We generated C. acnes–specific antimicrobial TH17 clones (AMTH17) with varying antimicrobial activity against C. acnes, which we correlated by RNA sequencing to the expression of transcripts encoding proteins that contribute to antimicrobial activity. Additionally, we validated that AMTH17-mediated killing of C. acnes and bacterial pathogens was dependent on the secretion of granulysin, granzyme B, perforin, and histone H2B. We found that AMTH17 cells can release fibrous structures composed of DNA decorated with histone H2B that entangle C. acnes that we call T cell extracellular traps (TETs). Within acne lesions, H2B and IL-17 colocalized in CD4+ T cells, in proximity to TETs in the extracellular space composed of DNA decorated with H2B. This study identifies a functionally distinct subpopulation of TH17 cells with an ability to form TETs containing secreted antimicrobial proteins that capture and kill bacteria.

Authors

George W. Agak, Alice Mouton, Rosane M.B. Teles, Thomas Weston, Marco Morselli, Priscila R. Andrade, Matteo Pellegrini, Robert L. Modlin

×

Figure 2

AMTH17 are CD4+ TEM and TEMRA cells and demonstrate antimicrobial activity as early as 6 hours.

Options: View larger image (or click on image) Download as PowerPoint

AMTH17 are CD4+ TEM and TEMRA cells and demonstrate antimicrobial activ...
(A) AMTH17 and n-AMTH17 clones were stimulated with α-CD3/α-CD28 and stained with antibodies against CD4, CD45RA, and CCR7. The AMTH17 clones consisted of primarily CD4+CD45RA+CCR7–RA (TEM) and CD4+CD45RA–CCR7– (TEMRA), whereas the n-AMTH17 clones consisted mainly of TEM and CD4+CD45RA–CCR7+ (TCM). Data are representative of 4 independent experiments using clones derived from 4 different donors. (B and C) Analysis of memory markers in AMTH17 clones (S5, S16, S26, and S28) and n-AMTH17 clones (S10, S13, S35, and S38) by flow cytometry (n = 4). ****P < 0.0001 by repeated-measures 1-way ANOVA for TEM compared with TCM, TEMRA, and naive T cells (TN). (D) Several AMTH17 and n-AMTH17 clones were stimulated with α-CD3/α-CD28 and supernatants used for CFU assays against C. acnes strain HL096PA1. The AMTH17 clones were subsequently stratified into High, Medium, and Low based on the results of the CFU assays. ****P < 0.001 by repeated-measures 1-way ANOVA, Low, Medium, and High killer AMTH17 compared with n-AMTH17. (E) Observed antimicrobial kinetics of supernatants derived from activated AMTH17 clones against several C. acnes strains (HL110PA1, HLA110PA3, HL043PA1, HL096PA1 HL005PA2, and ATCC6919) in CFU assays. Data are shown as mean ± SEM (n > 3). ****P < 0.0001 by repeated-measures 1-way ANOVA for treatment groups compared with C. acnes control.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts